Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
GPI heads into its October 28 earnings with a 10% short position, a wall of analyst downgrades, and its largest shareholder aggressively buying stock at the lows.
The most striking feature of the week is the divergence between what analysts are doing and what Conifer Management is doing. The Street is retreating fast. Morgan Stanley downgraded GPI to Underweight on October 5, cutting its target from $300 to $232, essentially the current price. UBS followed on October 7, trimming to $271 from $330 while staying Neutral. JP Morgan lowered its target to $260. Barclays, still the most constructive at Overweight, cut to $320 from $365. The consensus mean target of $353 flatters a picture that is actually moving sharply lower in real time. The direction of travel is unambiguous: the Street is trimming expectations across the board, and the one outright bear is now within touching distance of the share price.
Yet Conifer Management is moving the other way. The 10% owner filed a Schedule 13D amendment on September 29, lifting its stake from 12.7% to 15.4%, and the Form 4 trail shows why: Conifer bought nearly $17 million of GPI stock on September 30 alone, across eight separate transactions at prices between $238 and $245. Total net purchases over the past 90 days amount to roughly 468,000 shares worth approximately $115 million. These are open-market buys made without a 10b5-1 plan, a signal that this is discretionary conviction rather than a pre-scheduled programme. Conifer is now the second-largest holder at 16.2% of shares, just behind BlackRock at 17.3%. An activist on the register adding aggressively while the stock falls 21% in a month is one of the most newsworthy facts in this note. Stakes are as-last-disclosed around the 5% threshold, and a holder can fall below 5% without filing again, but the September 29 amendment and the Form 4 cluster leave little ambiguity about direction.
Short interest, at 10.2% of the free float, has been building gradually and is up 2.6% on the week, continuing a slow drift higher that has been in place since early September. The borrow market remains accessible, though. Availability runs at 542%, meaning there are more than five shares available to borrow for every share already shorted, well above the 52-week low of 355%. Cost to borrow is just 0.56%, up modestly from last month but nowhere near a squeeze setup. The ORTEX short score has crept from 56.4 to 59.1 over the past two weeks, a steady grind rather than a sharp signal, and the short-score factor rank sits in the 15th percentile, meaning most of the universe is more heavily shorted. Options traders are not showing unusual conviction either way: the put/call ratio of 1.05 is almost exactly in line with its 20-day average, with a z-score near zero.
The valuation case divides opinion sharply. At a price-to-earnings multiple of 5.7x and a price-to-book below 1x, GPI looks cheap in absolute terms. EV/EBITDA is 8.5x. The bull case rests on the Inchcape UK acquisition adding roughly $2.7 billion in annual revenue, an 11% lift in finance and insurance income, and the prospect of restructuring-driven margin improvement. The bear case is more immediate: projected AEBITDA down 5% to $990 million, adjusted EPS down 11% to $39.21, and EBITDA margins that have contracted to 4.6%. The factor profile reflects the tension. The forward EPS growth rank is in the 75th percentile, a signal that estimates are recovering from a low base, but EPS momentum over both 30 and 90 days sits in the 13th to 30th percentile, meaning near-term revisions are still heading south. Analyst recommendation sentiment ranks in the 5th percentile. Dividend data in the snapshot is stale and should not be relied upon for current yield analysis.
The last earnings print delivered a harsh reminder of how volatile this stock can be around results. GPI fell nearly 20% on the day of the July 30 release and extended that to a 24% five-day loss. The previous quarter, a year earlier, saw a 5% gain on the day and a 15% five-day rally. The range of outcomes is wide. Retail attention, as measured by Wikipedia page views, is running 1.5 standard deviations above its own 90-day average, suggesting the stock is drawing more eyeballs than usual.
With three weeks to the October 28 print, the central tension is between a shareholder who believes the stock is cheap enough to buy in size and an analyst community that keeps cutting its estimates. Whether the Inchcape integration delivers the margin improvement the bulls expect, and whether auto demand stabilises into year-end, are the questions the October print will start to answer.
See the live data behind this article on ORTEX.
Open GPI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
